Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.286 USD | -4.48% | +9.15% | -87.86% |
05-09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.86% | 19.3M | |
+9.87% | 115B | |
+11.90% | 106B | |
-2.59% | 21.96B | |
-12.53% | 21.87B | |
-5.29% | 19.21B | |
-3.85% | 18.08B | |
-38.57% | 17.71B | |
+7.14% | 14.32B | |
+35.70% | 12.42B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- Transcript : GlycoMimetics, Inc., Q1 2022 Earnings Call, Apr 28, 2022